Post COVID-19 burden: focus on the short-term condition

Fengwen Yang; Bo Pang; Xinyao Jin; Zhe Chen; Wentai Pang; Qingquan Liu; Junhua Zhang; Boli Zhang

doi:10.1097/HM9.0000000000000036

PDF(1582 KB)

Acupuncture and Herbal Medicine ›› 2022, Vol. 2 ›› Issue (3) : 139-142. DOI: 10.1097/HM9.0000000000000036

Editorial

Post COVID-19 burden: focus on the short-term condition

Fengwen Yang¹^,² ,
Bo Pang¹^,² ,
Xinyao Jin¹^,² ,
Zhe Chen¹^,² ,
Wentai Pang¹^,² ,
Qingquan Liu³ ,
Junhua Zhang¹^,² ,
Boli Zhang¹^,²

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Fengwen Yang, Bo Pang, Xinyao Jin, Zhe Chen, Wentai Pang, Qingquan Liu, Junhua Zhang, Boli Zhang. Post COVID-19 burden: focus on the short-term condition. Acupuncture and Herbal Medicine, 2022, 2(3): 139‒142 https://doi.org/10.1097/HM9.0000000000000036

References

Publishing order | Descend order by publishing year | Descend order by cited within

[[1]]

World Health Organization. WHO Coronavirus (COVID-19) dashboard; 2022. Available from: https://covid19.who.int.

[[2]]

U.S. Food & Drug Administration. Coronavirus (COVID-19) |Drugs; 2022. Available from: https://www.fda.gov/drugs/emergency-preparedness-drugs/coronavirus-covid-19-drugs.

[[3]]

COVID19 Vaccine Tracker Team. 11 vaccines granted emergency use listing (EUL) by WHO; 2022. Available from: https://covid19.trackvaccines.org/agency/who/.

[[4]]

Huang YF, Bai C, He F, et al. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19). Pharmacol Res. 2020;158:104939.

[[5]]

Crook H, Raza S, Nowell J, et al.Long COVID—mechanisms, risk factors, and management. BMJ. 2021;374:n1944.

[[6]]

Centers for Disease Control and Prevention. Long COVID or Post-COVID Condition; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.

[[7]]

Al-Aly Z, Bowe B, Xie Y.Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461-1467.

[[8]]

Perego E, Callard F, Stras L, et al.Why the patient-made term “long Covid” is needed. Wellcome Open Res. 2020;5(224):224224.

[[9]]

Greenhalgh T, Knight M, A’Court C, et al. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.

[[10]]

Nath A.Long-haul COVID. Neurology. 2020;95(13):559-560.

[[11]]

Baig AM.Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. [J] Med Virol. 2021;93(5):2555-2556.

[[12]]

Datta SD, Talwar A, Lee JT.A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251-2252.

[[13]]

National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. Available from: https://www.nice.org.uk/guidance/ng188.

[[14]]

Brodin P.Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28-33.

[[15]]

Nalbandian A, Sehgal K, Gupta A, et al.Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615.

[[16]]

National Institutes of Health. NIH launches new initiative to study “Long COVID”; 2022. Available from: https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid.

[[17]]

Fernández-de-Las-Peñas C, Palacios-Ceña D, Gó-Mayordomo V, et al. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18(5):2621.

[[18]]

Al-Aly Z, Xie Y, Bowe B.High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-264.

[[19]]

Centers for Diseases Control and Prevention. Post-COVID Condition; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.

[[20]]

World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October2021; 2022. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.

[[21]]

Yelin D, Moschopoulos CD, Margalit I, et al.ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28(7):955-972.

[[22]]

Osikomaiya B, Erinoso O, Wright KO, et al.“Long COVID”: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect Dis. 2021;21(1):304.

[[23]]

Sudre CH, Murray B, Varsavsky T, et al.Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-631.

[[24]]

Mahmud R, Rahman MM, Rassel MA, et al.Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16(4):e0249644.

[[25]]

Chopra V, Flanders SA, O’Malley M, et al. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576-578.

[[26]]

Venturelli S, Benatti SV, Casati M, et al.Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021;149:e32.

[[27]]

Taquet M, Luciano S, Geddes JR, et al.Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130-140.

[[28]]

Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al.Post-acute COVID-19 syndrome. Incidence and risk factors: a mediterranean cohort study. [J] Infect. 2021;82(3):378-383.

[[29]]

Goërtz YMJ, Van Herck M, Delbressine JM, et al.Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542-02020.

[[30]]

Xiong Q, Xu M, Li J, et al.Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89-95.

[[31]]

Morin L, Savale L, et al.; Writing Committee for the COMEBAC Study Group. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021;325(15):1525-1534.

[[32]]

Huang L, Li X, Gu X, et al.Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863-876.

[[33]]

Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur [J] Intern Med. 2021;92:55-70.

[[34]]

Chen C, Haupert SR, Zimmermann L, et al.Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis 2022; published online Apr 16. http://doi:10.1093/infdis/jiac136.

[[35]]

Wolter N, Jassat W, Walaza S, et al.Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437-446.

[[36]]

Office for National Statistics. Self-reported long COVID after infection with the Omicron variant in the UK: 6 May2022; 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/6may2022.

[[37]]

Brodin P, Casari G, Townsend L, et al.Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022;28(5):879-882.

[[38]]

Iacobucci G.Long COVID: “Holistic” approach is best, given range of symptoms, say researchers. BMJ. 2022;376:o336.

[[39]]

National Health Commission of China. Notice on the issuance of COVID-19 Diagnosis and Treatment Protocol (Trial Version 9); 2022. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202203/ b74ade1ba4494583805a3d2e 40093d88.shtml.

[[40]]

China Association of Chinese Medicine. Guidelines for rehabilitation of novel coronavirus pneumonia during the recovery phase of Chinese and Western medicine. Tianjin [J] Tradit Chin Med. 2020;37(05):484-489.

[[41]]

Central People’s Government of the People’s Republic of China. Notice on the issuance of TCM Rehabilitation Guidance and Suggestions for COVID-19 Recovery (Trial); 2020. Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/24/content_ 5482544.htm.

[[42]]

National Health Commission of China. Notification on the issuance of rehabilitation programs for major functional disorders of discharged COVID-19 patients; 2020. Available from: http://www.nhc.gov.cn/yzygj/s7653pd/202005/b15d59b5228341129cc8c5126f663b10.shtml

[[43]]

Traditional Chinese medicine expert group on prevention and treatment of COVID-19 in Tianjin. Rehabilitation program of coronavirus disease 2019 in Tianjin during rehabilitation period (Trial). Tianjin J Tradit Chin Med. 2022;39(3):275-277.

[[44]]

Health Commission of Hebei Province. Hebei Administration of Traditional Chinese Medicine, Rehabilitation Guidelines of Integrated Medicine for COVID-19 patients in Hebei Province; 2021. Available from: http://health.hebei.com.cn/system/2021/02/04/100592970.shtml.

[[45]]

Pang W, Yang F, Zhao Y, et al.Qingjin Yiqi granules for post-COVID-19 condition: a randomized clinical trial. [J] Evid Based Med. 2022;15(1):30-38.

[[46]]

Chen Y, Liu C, Wang T, et al.Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: a multicentre, double-blind, and randomised controlled trial. [J] Ethnopharmacol. 2022;284:114830.

[[47]]

Li L, An XD, Zhang Q, et al.Shumian capsule improves symptoms of sleep mood disorder in convalescent patients of Corona Virus Disease 2019. [J] Tradit Chin Med. 2021;41(6):974-981.

[[48]]

Li L, Gou CY, Li XM, et al.Effects of Chinese medicine on symptoms, syndrome evolution, and lung inflammation absorption in COVID-19 convalescent patients during 84-day follow-up after hospital discharge: a prospective cohort and nested case-control study. Chin [J] Integr Med. 2021;27(4):245-225.